After a particularly cruel winter, we have emerged from our
lairs to see The Sun and start thinking about Walking again.
Some new details:
The good news on MRF general fundraising this past year is
that The Conrad N. Hilton Foundation matched all donations and exceeded their commitment.
The very good news for us is we found an anonymous donor to match our
fundraising for our May Walk.
The more we stretch our efforts, the more they
will stretch their match.
The neuro-protective compound, that had been previously known
as MRF-008, is now identified as the FDA approved
drug for high blood pressure, guanabenz. The work on this drug, as to its
relevancy to MS, was done by the MRF collaborating principal investigators. You and The
Johnnie Walkers helped fund this work! The MRF has entered into a cooperative
agreement with the National Institutes of Health to get this breakthrough out of
the lab and into the pharmacy via MS human clinical
studies. Since guanabenz is already FDA-approved for another disease
indication, the MRF and the NIH see a tremendous opportunity to investigate the
repurposing of this drug with its known safety profile. Repurposing takes years
off the clinical trial protocols.
I’m excited about the fast start we’ve had already as depicted by the thermometer
to the right.
Join us on Sunday, May 3rd, in Lincolnshire to Walk, Generate Awareness and Raise Monies. The details remain the same as those in the November post below.
Posts
